Additionally, Oxytocin , known as the bonding hormone, is being investigated for its ability to reduce drug cravings and promote prosocial behavior
Written By: Pharmacally Medical News Desk Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025
For further queries, don't hesitate to contact us directly
There are a variety of internal and external factors that could hasten the onset of various skin conditions
11 Section S0, Non-Approved Substances, in WADAs classification system encompasses any compounds without approval by a governmental regulatory health authority for human therapeutic use, which would include all these injectable peptides